Cargando…
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection
In spite of increased awareness and the efforts taken to optimize Clostridium difficile infection (CDI) management, with the limited number of currently available antibiotics for C. difficile the halt of this increasing epidemic remains out of reach. There are, however, close to 80 alternative treat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336415/ https://www.ncbi.nlm.nih.gov/pubmed/27910000 http://dx.doi.org/10.1007/s40121-016-0140-z |